Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Pellagatti
Clonal Heterogeneity in the 5q- Syndrome: P53 Expressing Progenitors Prevail During Lenalidomide Treatment and Expand at Disease Progression
Haematologica
Hematology
Related publications
Unusual Clonal Evolution Involving 5q in a Case of Myelodysplastic Syndrome With Deletion 5q 31 Treated With Lenalidomide
Haematologica
Hematology
Lenalidomide in 5q Minus Myelodysplastic Syndrome: How Long Is Enough?
Annals of Hematology
Medicine
Hematology
Patients With Del(5q) MDS Who Fail to Achieve Sustained Erythroid or Cytogenetic Remission After Treatment With Lenalidomide Have an Increased Risk for Clonal Evolution and AML Progression
Annals of Hematology
Medicine
Hematology
Megakaryocytes Harbour the Del(5q) Abnormality Despite Complete Clinical and Cytogenetic Remission Induced by Lenalidomide Treatment
British Journal of Haematology
Hematology
Extended Survival and Reduced Risk of AML Progression in Erythroid-Responsive Lenalidomide-Treated Patients With Lower-Risk Del(5q) MDS
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Myeloproliferative Disease and Myelodysplastic Syndrome Induced by Transplantation of Bone Marrow Cells Expressing Mutant P53
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Clonal Ordering of 17p and 5q Allelic Losses in Barrett Dysplasia and Adenocarcinoma.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Modeling the Clonal Heterogeneity of Stem Cells
Theoretical Biology and Medical Modelling
Medicine
Modeling
Simulation
Health Informatics
A Critical Role for Phosphatase Haplodeficiency in the Selective Suppression of Deletion 5q MDS by Lenalidomide
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
